Assignee
NEOPHARM INC
US·6 granted patents·16 pending applications·131 citations·filing 1998–2007
Top patents by PatentIndex Score
22 records- 0192US6461637B1Method of administering liposomal encapsulated taxaneNEOPHARM INC·Filed 2000·Granted Oct 8, 2002·39 cites·17 claims
- 0286US6146659AMethod of administering liposomal encapsulated taxaneNEOPHARM INC·Filed 1998·Granted Nov 14, 2000·71 cites·15 claims
- 0380US7122553B2Liposomal formulation of irinotecanNEOPHARM INC·Filed 2003·Granted Oct 17, 2006·9 cites·24 claims
- 0473US7262173B2Chemosensitizing with liposomes containing oligonucleotidesNEOPHARM INC·Filed 2002·Granted Aug 28, 2007·7 cites·12 claims
- 0564US7390502B2SN-38 lipid complexes and their methods of useNEOPHARM INC·Filed 2003·Granted Jun 24, 2008·2 cites·14 claims
- 0656US2005202074A9Method of administering liposomal encapsulated taxaneNEOPHARM INC·Filed 2002·Application pending·0 cites
- 0752US2006034908A1Manufacturing process for liposomal preparationsNEOPHARM INC·Filed 2005·Application pending·0 cites
- 0851US2005148528A1Method for reducing platelet countNEOPHARM INC·Filed 2003·Application pending·0 cites
- 0951US2004228911A1Vinorelbine compositions and methods of useNEOPHARM INC·Filed 2004·Application pending·0 cites
- 1049US2005266068A1Cardiolipin molecules and methods of synthesisNEOPHARM INC·Filed 2005·Application pending·0 cites
- 1149US2006078560A1Method of inducing apoptosis and inhibiting cardiolipin synthesisNEOPHARM INC·Filed 2005·Application pending·0 cites
- 1248US2006030578A1Pharmaceutically active lipid based formulation of irinotecanNEOPHARM INC·Filed 2005·Application pending·0 cites
- 1347US2005249795A1Gemcitabine compositions for better drug deliveryNEOPHARM INC·Filed 2005·Application pending·0 cites
- 1446US2005002918A1Selective treatment of IL-13 expressing tumorsNEOPHARM INC·Filed 2004·Application pending·0 cites
- 1545US2005181037A1Cardiolipin compositions their methods of preparation and useNEOPHARM INC·Filed 2004·Application pending·0 cites
- 1644US2003219476A1Liposomal formulation of mitoxantroneNEOPHARM INC·Filed 2003·Application pending·0 cites
- 1743US2010323000A1Method and process for preparing cardiolipinNEOPHARM INC·Filed 2007·Application pending·0 cites
- 1842US2006165744A1Combination liposomal formulationsNEOPHARM INC·Filed 2004·Application pending·0 cites
- 1939US2005238706A1Pharmaceutically active lipid based formulation of SN-38NEOPHARM INC·Filed 2005·Application pending·0 cites
- 2038US2005277611A1Cationic cardiolipin analoges and its use thereofNEOPHARM INC·Filed 2005·Application pending·0 cites
- 2136US2006099652A1IL 13 receptor alpha 2 antibody and methods of useNEOPHARM INC·Filed 2005·Application pending·0 cites
- 2225US7314637B1Method of administering liposomal encapsulated taxaneNEOPHARM INC·Filed 1999·Granted Jan 1, 2008·3 cites·42 claims
Join the waitlist — get patent alerts
Get an alert when NEOPHARM INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →